IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Topsoe Jakob Haldor
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Topsoe Christina Teng
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director BEHRENS M KATHLEEN
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Thompson Elizabeth H.Z.
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Lee Michael Stewart
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Redmile Group, LLC
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Weber Steven
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Decker Lisa Lynn
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Harler Mary Beth
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Tahir Misbah
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Tahir Misbah
IGM Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(11.8%)
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Weber Steven
IGM Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(2.415%),Abigail P. Johnson(2.415%)
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Harler Mary Beth
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Redmile Group, LLC
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Lee Michael Stewart
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Topsoe Jakob Haldor
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Topsoe Christina Teng